La Jolla Institute for Immunology Acquires the Carterra LSA Platform to Advance State-of-the-Art Immunological and Infectious Disease Research

Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization dedicated to understanding the power of the immune system to promote human health, announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.


QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced today that its subsidiary, Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and services to hospitals, clinical laboratories and blood banks around the world, has earned the No. 1 ranking in the diagnostics industry for Overall Customer Satisfaction in the 2022 IMV ServiceTrak™ Awards for the fifth consecutive year. The ranking is based on interviews conducted with laboratory professionals, including Ortho’s customers, from more than 1,200 clinical testing locations operating over 1,900 collective instruments. The prestigious annual IMV ServiceTrak™ Awards rankings affirm the continued power and impact of Ortho’s innovative Ortho Care® Services and Informatics platform.

Open Lab Solutions Announces New Manufacturing Division to Initially focus on Medical Plastics

CHICAGO, July 26, 2022 /PRNewswire/ — AACC 2022 Open Lab Solutions, Inc., is announcing the formation of a new division, AMCAR Scientific, that will focus on an expanding product line of plastic consumables used in the medical industry. OLS is exhibiting within booth #3257 at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2022) at the McCormick Place Convention Center in Chicago, July 24 – 28th.

Athens Research and Technology, Inc. recognized as Exporter of the Year

The Georgia Department of Economic Development announced the winners of their annual Globe Awards on May 23rd, 2022. Among the awards were three top designations for Exporter of the Year. Athens Research and Technology, Inc. (ART) was the recipient of the Exporter of the Year award for a business with less than 20 employees. The award was presented at the laboratory to ART’s CEO, John Mitchell, on May 25th by Mary Waters, the Deputy Commissioner of International Trade for the State of Georgia.

LumiraDx to Present on Impact of its Next-Generation Microfluidic Technology at American Association for Clinical Chemistry (AACC) Annual Conference in Chicago

LumiraDx, a next-generation point of care diagnostics company will be hosting an industry workshop at this week’s American Association for Clinical Chemistry (AACC) Annual Conference in Chicago. The workshop, held on July 27th, will include data-backed insights on the impact of LumiraDx’s advanced microfluidic technology over lateral flow point-of-care antigen tests, and the role of these rapid immunoassays in response to the COVID-19 pandemic.


Cytovale®, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, will reveal its 510(k) pending Cytovale system and 10-minute IntelliSep® sepsis risk stratification test at the American Association for Clinical Chemistry (AACC) annual meeting, where new data featuring the test will also be shared. The instrument can be seen in the Cytovale booth, no. 5045, in the exhibit hall during Clinical Lab Expo hours. The IntelliSep test was recently named an AACC Disruptive Technology Award Semifinalist and is also being featured in the Disruptive Tech area of the exhibit hall during the meeting.


The planning for the world’s leading medical trade fair MEDICA 2022 as well as for COMPAMED 2022, the No. 1 trade fair for suppliers of the medical technology industry, has entered the next stage. The current number of exhibitor registrations indicates that participation will surpass last year’s results (MEDICA 2021: 3,033; COMPAMED 2021: 490). Exhibitors can still register online for all segments at and MEDICA and COMPAMED will take place concurrently from November 14 – 17, 2022 at the fairgrounds in Düsseldorf, Germany.

Dosing of highly viscous material for microencapsulation

Microencapsulation is becoming increasingly important in pharmaceutical, cosmetics, food and agricultural industries. New dosage forms are emerging and the efficacy is increasing. Precise metering techniques in the low-volume range are a necessary prerequisite for the production and processing of APIs. Metering pumps by HNP Mikrosysteme are a suitable technical solution.

Expanding diagnostics business: SCHOTT signs agreement to acquire Applied Microarrays Inc.

SCHOTT MINIFAB, a subsidiary of SCHOTT that develops and manufactures microfluidic devices for point-of-care and life sciences consumables, has had a long-standing close customer relationship with Applied Microarrays Inc. (AMI). Together, they develop biotech substrates for diagnostics applications.

20/20 GeneSystems Launches First Accelerator Facility for Innovative Clinical Lab Tests

20/20 GeneSystems, Inc., (“20/20”), announced the launch of its Clinical Lab Innovation Axcellerator (CLIAx), believed to be the first shared CLIA laboratory facility geared to helping diagnostic test innovators worldwide substantially reduce the time and cost of launching their tests in the U.S.

TE Connectivity acquires three life science development and manufacturing firms; expands reach into IVD, point of care and microfluidics segments

TE Connectivity, a world leader in connectors and sensors, has acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research and manufacturing. The companies are Toolbox Medical Innovations (USA), Wi Inc (USA) and microiLIQUID (Spain).

The combined entities leverage design and manufacturing capabilities in the United States and Europe and are focused on serving a global client base ranging from startups to multinationals in the life science, IVD and cell therapy markets.